Literature DB >> 3486093

Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsis.

A Luger, H Graf, H P Schwarz, H K Stummvoll, T A Luger.   

Abstract

The role of interleukin 1 (IL 1) in 16 patients with sepsis and 16 normal controls was investigated. Thymocyte costimulation was used to assay in vitro IL 1 levels produced by adherent cells in the peripheral blood, and in vivo IL 1 levels in the serum. Adherent cells (i.e., monocytes) from nonsurviving septic patients produced significantly less IL 1 activity than cells from healthy controls or surviving patients, either spontaneously or by silica stimulation. In contrast, in vitro IL 2 production by T lymphocytes was not altered in septic patients. Serum IL 1 activity was determined using serum fractions from high-pressure liquid chromatographic gel filtration. Suppressor factors in healthy subjects as well as septic patients usually eluted at molecular weights above 50 kilodaltons, while IL 1-like activity was normally present between 35 and 1 kilodaltons. Sera of nonsurviving septic patients contained significantly less IL 1 compared to that of controls or surviving patients. Thus, decreased serum IL 1 levels and diminished monocyte production of IL 1 appear to be negative prognostic indicators, possibly reflecting a breakdown of mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3486093     DOI: 10.1097/00003246-198605000-00004

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

Review 1.  The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy.

Authors:  T Darville; B Giroir; R Jacobs
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

2.  Inhalation injury severity and systemic immune perturbations in burned adults.

Authors:  Christopher S Davis; Scott E Janus; Michael J Mosier; Stewart R Carter; Jeffrey T Gibbs; Luis Ramirez; Richard L Gamelli; Elizabeth J Kovacs
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

3.  Differential cytokine production in stimulated blood cultures from intensive care patients with bacterial infections.

Authors:  I G Mitov; A Kropec; A Benzing; H Just; G Garotta; C Galanos; M Freudenberg
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

4.  Interleukin-1 secretion by blood monocytes of septic premature infants.

Authors:  I Srugo; A Berger; Z Lapidot; S Pollak
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

5.  The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats.

Authors:  J Mancilla; P García; C A Dinarello
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.